Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf Mounjaro doesn't seem to be working, the most useful first question is what 'working' means right now: weight loss slowing, appetite barely changed, or something else entirely? The answer shapes what happens next. Mounjaro is a tirzepatide-based prescription treatment that operates on two gut-hormone pathways, and its effects can look different at different stages of treatment. Most people who feel it isn't working are facing one of a handful of specific, addressable situations rather than a fundamental failure of the medicine. These are prescription-only medicines requiring clinical assessment, and your prescriber is the right person to review what's happening in your case.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro's starting dose (2.5mg) is there to let your body adjust. It's a settling-in period, not where the therapeutic effect lives. Many people notice very little appetite change in the first four weeks, and that's expected. The dose is titrated upward by your prescriber, typically in monthly steps, and meaningful appetite suppression and weight loss tend to build as the dose increases.
If you're several months in and on a mid-range or maintenance dose and still feel nothing is shifting, that's a different conversation from 'I've been on 2.5mg for three weeks.' Duration and current dose are the two facts your prescriber needs first. The full Mounjaro treatment overview explains how the titration schedule is structured and why it's set up the way it is.
There's also the question of how long you've been at your current dose. Bodies adapt over weeks, not days. A plateau that appears in week two of a new dose is not the same as one that's persisted for three months, and your prescriber will treat them very differently.
A common belief among people starting GLP-1 treatment is that they should feel dramatically different within a couple of weeks. It's understandable, the appetite-suppression effect can be vivid for some people and almost imperceptible for others at the same dose. Neither response is wrong; it's variation, not failure.
The more useful measure is the trend over eight to twelve weeks. Clinical trial data from the SURMOUNT programme, involving thousands of adults, tracked results over 72 weeks, because that's the timescale on which the medicine's full effect becomes clear. Short windows mislead. If you're weighing yourself daily and the number isn't moving in week five, that's one data point in a long sequence, not a verdict. The NHS medicines page for tirzepatide gives a plain summary of what to expect and when.
Lifestyle factors matter here too. Mounjaro works alongside a reduced-calorie diet and increased activity, those aren't optional footnotes. If eating patterns haven't changed much alongside treatment, the medicine's appetite effect may be offset. Worth an honest look before concluding the dose isn't working.
This is a distinct pattern, and one worth distinguishing from 'never really worked.' Some people find that a dose that was producing steady results seems to plateau. There are several reasons this happens: the body adapts, weight loss itself changes the calorie equation, or adherence to diet and activity has drifted. None of these is unusual and all of them are things a prescriber can help with.
A prescriber may consider whether a dose increase is appropriate, whether the current dose has been given enough time, or whether there are other factors in play. That clinical conversation is exactly what the deeper review of why Mounjaro might not be working should involve. There's also a practical angle on cost: if you're wondering whether switching or changing approach is worth it, the Mounjaro cost context page explains how private treatment is structured and what's included.
One thing to flag: sudden complete loss of appetite suppression after it was working clearly could occasionally have a practical cause, pen storage, injection technique, or an inadvertent missed dose. These are worth ruling out with your pharmacist before drawing any clinical conclusions. The MHRA's Yellow Card service is where unexpected or unexplained changes in how a medicine behaves can be reported.
The decision you're really making is whether to stay at the current dose, request a review, or discuss a change in approach. None of those is something to navigate alone, and none requires guesswork. Your prescriber has the clinical picture: your current dose, how long you've been on it, your starting weight and what's happened since.
If you're a patient asking whether Mounjaro has stopped working after a longer period of treatment, the dedicated page on Mounjaro stopping working over time covers that pattern specifically. If you're earlier in treatment and wondering whether the medicine works for everyone, why Mounjaro doesn't work for some people addresses the individual variation in response. And if you want a broader look at how different weight-loss treatments compare, our treatment overview is a good place to start.
Our prescribers hear this concern regularly, it's one of the most common questions we get. If you'd like a clinical review of where you are in your treatment, you're welcome to speak to our prescribers directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.